The Effect of Different Doses of Botulinum Toxin on Masseter Muscle in Patients with Bruxism.
Background and Objectives: Botulinum toxin type A is produced by clostridium botulinum. It acts by inhibiting the release of acetylcholine from cholinergic neurons. Botulinum toxin has been used for management of bruxism, which is a parafunctional disorder and characterized by clenching or grinding...
Saved in:
Main Authors: | Kawa F. Dizaye, Sarezh Jamal Jalal |
---|---|
Format: | Article |
Language: | English |
Published: |
College Of Dentistry Hawler Medical University
2022-02-01
|
Series: | Erbil Dental Journal |
Subjects: | |
Online Access: | https://edj.hmu.edu.krd/index.php/journal/article/view/139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bruxism as a neurological problem (literature review)
by: O. R. Orlova, et al.
Published: (2018-04-01) -
Bruxism: methods of application and results of treatment with botulinum neuroprotein (Relatox)
by: O. R. Orlova, et al.
Published: (2019-07-01) -
EMG-CHARACTERISTICS OF MASTICATORY MUSCLES IN SUBJECTS WITH BRUXISM
by: L.V. Smaglyuk, et al.
Published: (2022-03-01) -
Hemimasticatory spasm. Own experience of using botulinum neuroprotein type A
by: A. N. Korenko, et al.
Published: (2022-04-01) -
BOTULINUM TOXIN FOR THE TREATMENT OF CHRONIC HEADACHE
by: L. B. Zavaliy, et al.
Published: (2016-03-01)